Clinical Trial Update: A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating neoadjuvant chemotherapy with concurrent chemoradiotherapy plus dual immune checkpoint blockade in locally advanced non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Cancer (NSCLC) | Phase 2 | Status: RECRUITING